Cell-cell interactions in rheumatoid arthritis synovium

Rheumatic Disease Clinics of North America

Volumn 36, Issue 2, 2010, Pages 311-323

  Fox, David A ^a   Gizinski, Alison ^a   Morgan, Rachel ^a   Lundy, Steven K ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Antigen presenting cells; B lymphocytes; Cytokines; Endothelial cells; Synovial fibroblasts; T lymphocytes

Indexed keywords

B CELL ACTIVATING FACTOR; B7 ANTIGEN; B7 H3 ANTIGEN; CADHERIN; CADHERIN 11; CHEMOKINE RECEPTOR CX3CR1; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ETANERCEPT; FRACTALKINE; INDOLEAMINE 2,3 DIOXYGENASE; INFLIXIMAB; INTERLEUKIN 15; INTERLEUKIN 7; KYNURENINE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; METHOTREXATE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; OX40 LIGAND; TOCILIZUMAB; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ARTHRITIS; AUTOCRINE EFFECT; B LYMPHOCYTE; BIOLOGICAL THERAPY; CD4+ T LYMPHOCYTE; CELL INTERACTION; CELL STRUCTURE; CELL TYPE; CELLULAR DISTRIBUTION; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG TARGETING; ENDOTHELIUM CELL; FIBROBLAST; GERMINAL CENTER; HUMAN; IMMUNOPATHOGENESIS; LEUKOCYTE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOID TISSUE; NATURAL KILLER T CELL; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; CELL COMMUNICATION; ENDOTHELIAL CELLS; FIBROBLASTS; HUMANS; SYNOVIAL MEMBRANE; T-LYMPHOCYTES;

EID: 77953274065     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2010.02.004     Document Type: Review

References (52)

1. Valencia X., Higgins J.M., Kiener H.P., et al. Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes. J Exp Med 2004, 200:1673.
2. Lee D.M., Kiener H.P., Agarwal S.K., et al. Cadherin-11 in synovial lining formation and pathology in arthritis. Science 2007, 315:1006.
3. Vandooren B., Cantaert T., ter Borg M., et al. Tumor necrosis factor alpha drives cadherin 11 expression in rheumatoid inflammation. Arthritis Rheum 2008, 58:3051.
4. Volin M.V., Huynh N., Klosowska K., et al. Fractalkine is a novel chemoattractant for rheumatoid arthritis fibroblast-like synoviocyte signaling through MAP kinases and Akt. Arthritis Rheum 2007, 56:2512.
5. Sawai H., Park Y.W., He X., et al. Fractalkine mediates T cell-dependent proliferation of synovial fibroblasts in rheumatoid arthritis. Arthritis Rheum 2007, 56:3215.
6. Benito-Miguel M., Garcia-Carmona Y., Balsa A., et al. A dual action of rheumatoid arthritis synovial fibroblast IL-15 expression on the equilibrium between CD4+CD25+ regulatory T cells and CD4+CD25- responder T cells. J Immunol 2009, 183:8268.
7. Dubois S., Mariner J., Waldmann T.A., et al. IL-15Ralpha recycles and presents IL-15 in trans to neighboring cells. Immunity 2002, 17:537.
8. Baslund B., Tvede N., Danneskiold-Samsoe B., et al. Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis Rheum 2005, 52:2686.
9. Tran C.N., Davis M.J., Tesmer L.A., et al. Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes. Arthritis Rheum 2007, 56:1497.
10. Tran C.N., Thacker S.G., Louie D.M., et al. Interactions of T cells with fibroblast-like synoviocytes: role of the B7 family costimulatory ligand B7-H3. J Immunol 2008, 180:2989.
11. Modak S., Kramer K., Gultekin S.H., et al. Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors. Cancer Res 2001, 61:4048.
12. Xu H., Cheung I.Y., Guo H.F., et al. MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. Cancer Res 2009, 69:6275.
13. Munn D.H., Sharma M.D., Mellor A.L. Ligation of B7-1/B7-2 by human CD4 + T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J Immunol 2004, 172:4100.
14. Szanto S., Koreny T., Mikecz K., et al. Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice. Arthritis Res Ther 2007, 9:R50.
15. Criado G., Simelyte E., Inglis J.J., et al. Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis. Arthritis Rheum 2009, 60:1342.
16. Leucocyte and stromal cell molecules: the CD markers 2007, 412. Wiley-Liss, Hoboken (NJ). H. Zola (Ed.).
17. Ohshima Y., Tanaka Y., Tozawa H., et al. Expression and function of OX40 ligand on human dendritic cells. J Immunol 1997, 159:3838.
18. Brugnoni D., Bettinardi A., Malacarne F., et al. CD134/OX40 expression by synovial fluid CD4+ T lymphocytes in chronic synovitis. Br J Rheumatol 1998, 37:584.
19. Yoshioka T., Nakajima A., Akiba H., et al. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis. Eur J Immunol 2000, 30:2815.
20. Giacomelli R., Passacantando A., Perricone R., et al. T lymphocytes in the synovial fluid of patients with active rheumatoid arthritis display CD134-OX40 surface antigen. Clin Exp Rheumatol 2001, 19:317.
21. Passacantando A., Parzanese I., Rascente M., et al. Synovial fluid OX40T lymphocytes of patients with rheumatoid arthritis display a Th2/Th0 polarization. Int J Immunopathol Pharmacol 2006, 19:499.
22. Hirota K., Yoshitomi H., Hashimoto M., et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 2007, 204:2803.
23. Ruth J.H., Shahrara S., Park C.C., et al. Role of macrophage inflammatory protein-3alpha and its ligand CCR6 in rheumatoid arthritis. Lab Invest 2003, 83:579.
24. Kageyama Y., Ichikawa T., Nagafusa T., et al. Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis. Rheumatol Int 2007, 28:137.
25. Chabaud M., Page G., Miossec P. Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J Immunol 2001, 167:6015.
26. Tanida S., Yoshitomi H., Nishitani K., et al. CCL20 produced in the cytokine network of rheumatoid arthritis recruits CCR6+ mononuclear cells and enhances the production of IL-6. Cytokine 2009, 47:112.
27. Kawashiri S.Y., Kawakami A., Iwamoto N., et al. Proinflammatory cytokines synergistically enhance the production of chemokine ligand 20 (CCL20) from rheumatoid fibroblast-like synovial cells in vitro and serum CCL20 is reduced in vivo by biologic disease-modifying antirheumatic drugs. J Rheumatol 2009, 36:2397.
28. Timmer T.C., Baltus B., Vondenhoff M., et al. Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology: identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis. Arthritis Rheum 2007, 56:2492.
29. van Roon J.A., Jacobs K., Verstappen S., et al. Reduction of serum interleukin 7 levels upon methotrexate therapy in early rheumatoid arthritis correlates with disease suppression. Ann Rheum Dis 2008, 67:1054.
30. Hartgring S.A., van Roon J.A., Wenting-van Wijk M., et al. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis. Arthritis Rheum 2009, 60:2595.
31. Levesque M.C. Translational mini-review series on B cell-directed therapies: recent advances in B cell-directed biological therapies for autoimmune disorders. Clin Exp Immunol 2009, 157:198.
32. Humby F., Bombardieri M., Manzo A., et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 2009, 6:e1.
33. Manzo A., Vitolo B., Humby F., et al. Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint. Arthritis Rheum 2008, 58:3377.
34. Iwai H., Kozono Y., Hirose S., et al. Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation. J Immunol 2002, 169:4332.
35. Hu Y.L., Metz D.P., Chung J., et al. B7RP-1 blockade ameliorates autoimmunity through regulation of follicular helper T cells. J Immunol 2009, 182:1421.
36. Matsushita T., Yanaba K., Bouaziz J.D., et al. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 2008, 118:3420.
37. Coppieters K., Dewint P., Van Beneden K., et al. NKT cells: manipulable managers of joint inflammation. Rheumatology (Oxford) 2007, 46:565.
38. Parietti V., Chifflot H., Sibilia J., et al. Rituximab treatment overcomes reduction of regulatory iNKT cells in patients with rheumatoid arthritis. Clin Immunol 2009, 134:331-339.
39. Rochas C., Hillion S., Saraux A., et al. Transmembrane BAFF from rheumatoid synoviocytes requires interleukin-6 to induce the expression of recombination-activating gene in B lymphocytes. Arthritis Rheum 2009, 60:1261.
40. Lai Kwan Lam Q., King Hung Ko O., Zheng B.J., et al. Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc Natl Acad Sci U S A 2008, 105:14993.
41. Take Y., Nakata K., Hashimoto J., et al. Specifically modified osteopontin in rheumatoid arthritis fibroblast-like synoviocytes supports interaction with B cells and enhances production of interleukin-6. Arthritis Rheum 2009, 60:3591.
42. Han X., Lin X., Seliger A.R., et al. Expression of receptor activator of nuclear factor-kappaB ligand by B cells in response to oral bacteria. Oral Microbiol Immunol 2009, 24:190.
43. Szekanecz Z., Koch A.E. Vascular involvement in rheumatic diseases: 'vascular rheumatology'. Arthritis Res Ther 2008, 10:224.
44. Gal I., Bajnok E., Szanto S., et al. Visualization and in situ analysis of leukocyte trafficking into the ankle joint in a systemic murine model of rheumatoid arthritis. Arthritis Rheum 2005, 52:3269.
45. Sarraj B., Ludanyi K., Glant T.T., et al. Expression of CD44 and L-selectin in the innate immune system is required for severe joint inflammation in the proteoglycan-induced murine model of rheumatoid arthritis. J Immunol 1932, 177:2006.
46. Lally F., Smith E., Filer A., et al. A novel mechanism of neutrophil recruitment in a coculture model of the rheumatoid synovium. Arthritis Rheum 2005, 52:3460.
47. McGettrick H.M., Smith E., Filer A., et al. Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells. Eur J Immunol 2009, 39:113.
48. Binstadt B.A., Patel P.R., Alencar H., et al. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat Immunol 2006, 7:284.
49. Silverman M.D., Haas C.S., Rad A.M., et al. The role of vascular cell adhesion molecule 1/very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium. Arthritis Rheum 2007, 56:1817.
50. Izquierdo E., Canete J.D., Celis R., et al. Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapy. PLoS One 2009, 4:e8131.
51. Amin M.A., Ruth J.H., Haas C.S., et al. H-2g, a glucose analog of blood group H antigen, mediates mononuclear cell recruitment via Src and phosphatidylinositol 3-kinase pathways. Arthritis Rheum 2008, 58:689.
52. Burman A., Haworth O., Hardie D.L., et al. A chemokine-dependent stromal induction mechanism for aberrant lymphocyte accumulation and compromised lymphatic return in rheumatoid arthritis. J Immunol 2005, 174:1693.